Literature DB >> 20026763

Neointimal hyperplasia and vasoreactivity are controlled by genetic elements on rat chromosome 3.

Andrea L Nestor Kalinoski1, Ramona S Ramdath, Kay M Langenderfer, Saad Sikanderkhel, Sarah Deraedt, Marlene Welch, James L Park, Timothy Pringle, Bina Joe, George T Cicila, David C Allison.   

Abstract

Neointimal hyperplasia (NIH) can lead to restenosis after clinical vascular interventions. NIH results from complex and poorly understood interactions between signaling cascades in the extracellular matrix and the disrupted endothelium, which lead to vessel occlusion. Quantitative trait loci (QTLs) were reported previously on rat chromosomes 3 and 6 through linkage analysis of postinjury NIH in midiliac arterial sections. In the current study, substitution mapping validated the RNO3 NIH QTL but not the RNO6 NIH QTL. The SHR.BN3 congenic strain had a 3-fold increase in the percentage of NIH compared with the parental spontaneously hypertensive rat strain. A double congenic study of RNO3+RNO6 NIH QTL segments suggested less than additive effects of these 2 genomic regions. To test the hypothesis that changes in vessel dynamics account for the differences in NIH formation, we performed vascular reactivity studies in the Brown Norway (BN), spontaneously hypertensive rat (SHR), SHR.BN3, and SHR.BN6 strains. De-endothelialized left common carotid artery rings of the SHR.BN3 showed an increased vascular responsiveness when treated with serotonin or prostaglandin F2(alpha), with significant differences in EC(50) and maximum effect (P<0.01) values compared with the spontaneously hypertensive rat parental strain. Because both vascular reactivity and percentage of NIH formation in the SHR.BN3 strain are significantly higher than the SHR strain, we postulate that these traits may be associated and are controlled by genetic elements on RNO3. In summary, these results confirm that the RNO3 NIH QTL carries the gene(s) contributing to postinjury NIH formation.

Entities:  

Mesh:

Year:  2009        PMID: 20026763      PMCID: PMC3765071          DOI: 10.1161/HYPERTENSIONAHA.109.142505

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

1.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

Authors:  J N Wilcox; K M Smith; L T Williams; S M Schwartz; D Gordon
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

2.  Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions.

Authors:  A M Imparato; A Bracco; G E Kim; R Zeff
Journal:  Surgery       Date:  1972-12       Impact factor: 3.982

3.  Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoral-popliteal bypass.

Authors:  V Echave; A R Koornick; M Haimov; J H Jacobson
Journal:  Surgery       Date:  1979-12       Impact factor: 3.982

4.  Long-term follow-up and clinical outcome of carotid restenosis.

Authors:  D A Healy; R E Zierler; S C Nicholls; A W Clowes; J F Primozich; R O Bergelin; D E Strandness
Journal:  J Vasc Surg       Date:  1989-12       Impact factor: 4.268

5.  Growth factor expression in aorta of normotensive and hypertensive rats.

Authors:  R Sarzani; P Brecher; A V Chobanian
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Dissecting quantitative trait loci into opposite blood pressure effects on Dahl rat chromosome 8 by congenic strains.

Authors:  Anita Ariyarajah; Ana Palijan; Julie Dutil; Kalyani Prithiviraj; Yishu Deng; Alan Y Deng
Journal:  J Hypertens       Date:  2004-08       Impact factor: 4.844

7.  Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts.

Authors:  B H Bulkley; G M Hutchins
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

8.  Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.

Authors:  James L Park; Liming Shu; James A Shayman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-06       Impact factor: 4.733

9.  The three-dimensional architecture of the elastic-fiber network in canine hepatic portal system.

Authors:  R S Crissman; W Guilford
Journal:  Am J Anat       Date:  1984-12

Review 10.  Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

Authors:  M W Liu; G S Roubin; S B King
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

View more
  5 in total

1.  ABCG1 regulates mouse adipose tissue macrophage cholesterol levels and ratio of M1 to M2 cells in obesity and caloric restriction.

Authors:  Hao Wei; Elizabeth J Tarling; Timothy S McMillen; Chongren Tang; Renée C LeBoeuf
Journal:  J Lipid Res       Date:  2015-10-21       Impact factor: 5.922

2.  Intima modifier locus 2 controls endothelial cell activation and vascular permeability.

Authors:  Elaine M Smolock; Ryan M Burke; Chenjing Wang; Tamlyn Thomas; Sri N Batchu; Xing Qiu; Martha Zettel; Keigi Fujiwara; Bradford C Berk; Vyacheslav A Korshunov
Journal:  Physiol Genomics       Date:  2014-07-01       Impact factor: 3.107

3.  RNO3 QTL regulates vascular structure and arterial stiffness in the spontaneously hypertensive rat.

Authors:  Eric E Morgan; Michael P Morran; Nicholas G Horen; David A Weaver; Andrea L Nestor-Kalinoski
Journal:  Physiol Genomics       Date:  2021-11-10       Impact factor: 4.297

4.  In vivo assessment of arterial stiffness in the isoflurane anesthetized spontaneously hypertensive rat.

Authors:  Eric E Morgan; Andrew B Casabianca; Samer J Khouri; Andrea L Nestor Kalinoski
Journal:  Cardiovasc Ultrasound       Date:  2014-09-17       Impact factor: 2.062

5.  Dissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3.

Authors:  H H Caline Koh-Tan; Mohammed Dashti; Ting Wang; Wendy Beattie; John Mcclure; Barbara Young; Anna F Dominiczak; Martin W McBride; Delyth Graham
Journal:  J Hypertens       Date:  2017-02       Impact factor: 4.844

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.